Your PlexusDx clinician will recommend the formulation and compound combination that aligns with your genetic profile and treatment history
It is not licensed by the MHRA or EMA and remains in Phase 3 clinical investigation
Arabic gum, brewers yeast, calcium sulfate, canola oil, citric acid, citrus pectin, glycerin, hydrolyzed chicken liver flavor, maltodextrin, mixed tocopherols, oat flour, oat meal, propionic acid, rosemary extract, rye flour, silicon dioxide, sodium alginate, sorbic acid, soy lecithin, vegetable oil, and water
Insulin sensitivity & glucose metabolism investigated in models of insulin resistance and metabolic stress for effects on glucose uptake and glycaemic control
This effect may contribute to ensuring that a higher percentage of weight lost while using a GLP-1 medication comes from excess body fat rather than muscle mass